Analyzing Fortrea (NASDAQ:FTRE) and RadNet (NASDAQ:RDNT)

Fortrea (NASDAQ:FTREGet Free Report) and RadNet (NASDAQ:RDNTGet Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

Profitability

This table compares Fortrea and RadNet’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Fortrea -10.99% 2.00% 0.80%
RadNet -0.25% 4.29% 1.45%

Risk and Volatility

Fortrea has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Comparatively, RadNet has a beta of 1.79, suggesting that its stock price is 79% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Fortrea and RadNet, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fortrea 1 11 0 0 1.92
RadNet 0 0 4 1 3.20

Fortrea presently has a consensus target price of $23.30, suggesting a potential upside of 47.47%. RadNet has a consensus target price of $75.50, suggesting a potential upside of 12.43%. Given Fortrea’s higher possible upside, equities analysts plainly believe Fortrea is more favorable than RadNet.

Insider & Institutional Ownership

77.9% of RadNet shares are owned by institutional investors. 0.1% of Fortrea shares are owned by insiders. Comparatively, 5.1% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Fortrea and RadNet”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Fortrea $3.11 billion 0.46 -$3.40 million ($3.42) -4.62
RadNet $1.62 billion 3.07 $3.04 million ($0.07) -959.15

RadNet has lower revenue, but higher earnings than Fortrea. RadNet is trading at a lower price-to-earnings ratio than Fortrea, indicating that it is currently the more affordable of the two stocks.

Summary

RadNet beats Fortrea on 12 of the 15 factors compared between the two stocks.

About Fortrea

(Get Free Report)

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

About RadNet

(Get Free Report)

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Receive News & Ratings for Fortrea Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortrea and related companies with MarketBeat.com's FREE daily email newsletter.